Chronic caffeine consumption prevents cognitive decline from young to middle age in rats, and is associated with increased length, branching, and spine density of basal dendrites in CA1 hippocampal neurons

Neuroscience

Volumn 202, Issue , 2012, Pages 384-395

  Vila Luna, S ^a   Cabrera Isidoro, S ^b   Vila Luna, L ^a   Juarez Diaz I ^b   Bata Garcia J L ^a   Alvarez Cervera, F J ^a   Zapata Vazquez R E ^a,c   Arankowsky Sandoval, G ^a   Heredia Lopez F ^a   Flores, G ^b   Gongora Alfaro J L ^a  

^a UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^b BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Aging; Caffeine; Dendritic growth; Memory; Methylxanthines; Neuroprotection

Indexed keywords

CAFFEINE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC BRANCHING; DENTRITIC LENGTH; DIETARY INTAKE; EXPLORATORY BEHAVIOR; FLUID INTAKE; GOLGI STAIN; HABITUATION; HIPPOCAMPAL CA1 REGION; LONG TERM CARE; MALE; MENTAL DETERIORATION; MIDDLE AGED; MORPHOMETRICS; MOTOR DYSFUNCTION; NERVE GROWTH; NERVOUS SYSTEM PARAMETERS; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SPINE DENSITY; WORKING MEMORY;

AGING; ANIMALS; ANXIETY; CA1 REGION, HIPPOCAMPAL; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; DATA INTERPRETATION, STATISTICAL; DENDRITES; ELECTROPHYSIOLOGICAL PHENOMENA; EXPLORATORY BEHAVIOR; LEARNING; MALE; MAZE LEARNING; MEMORY, SHORT-TERM; MOTOR ACTIVITY; MOVEMENT; NEURONS; RATS; RATS, WISTAR;

EID: 84856221308     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.11.053     Document Type: Article

References (55)

1. Altun M., Bergman E., Edström E., Johnson H., Ulfhake B. Behavioral impairments of the aging rat. Physiol Behav 2007, 92:911-923.
2. Arendash G.W., Mori T., Cao C., Mamcarz M., Runfeldt M., Dickson A., Rezai-Zadeh K., Tan J., Citron B.A., Lin X., Echeverria V., Potter H. Caffeine reverses cognitive impairment and decreases brain amyloid-β levels in aged Alzheimer's disease mice. J Alzheimers Dis 2009, 17:661-680.
3. Arendash G.W., Schleif W., Rezai-Zadeh K., Jackson E.K., Zacharia L.C., Cracchiolo J.R., Shippy D., Tan J. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain β-amyloid production. Neuroscience 2006, 142:941-952.
4. Balkowiec A., Katz D.M. Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons. J Neurosci 2002, 22:10399-10407.
5. Bert B., Fink H., Huston J.P., Voits M. Fischer 344 and Wistar rats differ in anxiety and habituation but not in water maze performance. Neurobiol Learn Mem 2002, 78:11-22.
6. Burgess J.W., Monachello M.P. Chronic exposure to caffeine during early development increases dendritic spine and branch formation in midbrain optic tectum. Brain Res 1983, 282:123-129.
7. Cao C., Cirrito J.R., Lin X., Wang L., Verges D.K., Dickson A., Mamcarz M., Zhang C., Mori T., Arendash G.W., Holtzman D.M., Potter H. Caffeine suppresses amyloid-β levels in plasma and brain of Alzheimer's disease transgenic mice. J Alzheimers Dis 2009, 17:681-697.
8. Costa M.S., Botton P.H., Mioranzza S., Souza D.O., Porciúncula L.O. Caffeine prevents age-associated recognition memory decline and changes brain-derived neurotrophic factor and tirosine kinase receptor (TrkB) content in mice. Neuroscience 2008, 153:1071-1078.
9. Costenla A.R., Cunha R.A., de Mendonça A. Caffeine, adenosine receptors, and synaptic plasticity. J Alzheimers Dis 2010, 20(Suppl 1):S25-S34.
10. 2A receptors in the modulation of LTP in the rat hippocampus upon ageing. Eur J Neurosci 2011, 34:12-21.
11. Cunha R.A., Agostinho P.M. Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline. J Alzheimers Dis 2010, 20(Suppl 1):S95-S116.
12. 2a receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice. Exp Neurol 2007, 203:241-245.
13. Diana M., Spiga S., Acquas E. Persistent and reversible morphine withdrawal-induced morphological changes in the nucleus accumbens. Ann N Y Acad Sci 2006, 1074:446-457.
14. Dobi A., Seabold G.K., Christensen C.H., Bock R., Alvarez V.A. Cocaine-induced plasticity in the nucleus accumbens is cell specific and develops without prolonged withdrawal. J Neurosci 2011, 31:1895-1904.
15. 2A adenosine receptor antagonists. Psychopharmacology (Berl) 2000, 148:153-163.
16. Eskelinen M.H., Kivipelto M. Caffeine as a protective factor in dementia and Alzheimer's disease. J Alzheimers Dis 2010, 20(Suppl 1):S167-S174.
17. Espinola E.B., Dias R.F., Mattei R., Carlini E.A. Pharmacological activity of guarana (Paullinia cupana Mart.) in laboratory animals. J Ethnopharmacol 1997, 55:223-229.
18. Fraley S.M., Springer A.D. Memory of simple learning in young, middle-aged, and aged C57/BL6 mice. Behav Neural Biol 1981, 31:1-7.
19. Fredholm B.B., Bättig K., Holmén J., Nehlig A., Zvartau E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999, 51:83-133.
20. Gerlai R. A new continuous alternation task in T-maze detects hippocampal dysfunction in mice: a strain comparison and lesion study. Behav Brain Res 1998, 95:91-101.
21. Gibb R., Kolb B. A method for vibratome sectioning of Golgi-cox stained whole rat brain. J Neurosci Methods 1998, 79:1-4.
22. Góngora-Alfaro J.L., Moo-Puc R.E., Villanueva-Toledo J.R., Alvarez-Cervera F.J., Bata-García J.L., Heredia-López F.J., Pineda J.C. Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine. Neurosci Lett 2009, 463:210-214.
23. Hameleers P.A., Van Boxtel M.P., Hogervorst E., Riedel W.J., Houx P.J., Buntinx F., Jolles J. Habitual caffeine consumption and its relation to memory, attention, planning capacity and psychomotor performance across multiple age groups. Hum Psychopharmacol 2000, 15:573-581.
24. Holtzman S.G. Complete, reversible, drug-specific tolerance to stimulation of locomotor activity by caffeine. Life Sci 1983, 33:779-787.
25. Hooper N., Fraser C., Stone T.W. Effects of purine analogues on spontaneous alternation in mice. Psychopharmacology (Berl) 1996, 123:250-257.
26. Johnson-Kozlow M., Kritz-Silverstein D., Barrett-Connor E., Morton D. Coffee consumption and cognitive function among older adults. Am J Epidemiol 2002, 156:842-850.
27. Juárez-Méndez S., Carretero R., Martínez-Tellez R., Silva-Gómez A.B., Flores G. Neonatal caffeine administration causes a permanent increase in the dendritic length of prefrontal cortical neurons of rats. Synapse 2006, 60:450-455.
28. Kumar A. Long-term potentiation at CA3-CA1 hippocampal synapses with special emphasis on aging, disease, and stress. Front Aging Neurosci 2011, 3:7.
29. Lee S.E., Simons S.B., Heldt S.A., Zhao M., Schroeder J.P., Vellano C.P., Cowan D.P., Ramineni S., Yates C.K., Feng Y., Smith Y., Sweatt J.D., Weinshenker D., Ressler K.J., Dudek S.M., Hepler J.R. RGS14 is a natural suppressor of both synaptic plasticity in CA2 neurons and hippocampal-based learning and memory. Proc Natl Acad Sci U S A 2010, 107:16994-16998.
30. Leussis M.P., Bolivar V.J. Habituation in rodents: a review of behavior, neurobiology, and genetics. Neurosci Biobehav Rev 2006, 30:1045-1064.
31. Lindsay J., Laurin D., Verreault R., Hébert R., Helliwell B., Hill G.B., McDowell I. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian study of health and aging. Am J Epidemiol 2002, 156:445-453.
32. Lolova I. Dendritic changes in the hippocampus of aged rats. Acta Morphol Hung 1989, 37:3-10.
33. Maia L., de Mendonça A. Does caffeine intake protect from Alzheimer's disease?. Eur J Neurol 2002, 9:377-382.
34. Miyagawa H., Hasegawa M., Fukuta T., Amano M., Yamada K., Nabeshima T. Dissociation of impairment between spatial memory, and motor function and emotional behavior in aged rats. Behav Brain Res 1998, 91:73-81.
35. Ochiishi T., Saitoh Y., Yukawa A., Saji M., Ren Y., Shirao T., Miyamoto H., Nakata H., Sekino Y. High level of adenosine A1 receptor-like immunoreactivity in the CA2/CA3a region of the adult rat hippocampus. Neuroscience 1999, 93:955-967.
36. Paxinos G., Watson W. The rat brain in stereotaxic coordinates 1986, Academic Press, San Diego. 2nd ed.
37. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985, 14:149-167.
38. 2A receptors in the mouse hippocampus. Neuropharmacology 2009, 56:481-492.
39. Pokorný J., Yamamoto T. Postnatal ontogenesis of hippocampal CA1 area in rats: part I. Development of dendritic arborisation in pyramidal neurons. Brain Res Bull 1981, 7:113-120.
40. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003, 463:3-33.
41. 1 receptors for the diuretic and natriuretic action of the methylxanthines theophylline and caffeine. J Pharmacol Exp Ther 2005, 313:403-409.
42. Ritchie K., Carrière I., de Mendonca A., Portet F., Dartigues J.F., Rouaud O., Barberger-Gateau P., Ancelin M.L. The neuroprotective effects of caffeine: a prospective population study (the three city study). Neurology 2007, 69:536-545.
43. Ropireddy D., Ascoli G.A. Potential synaptic connectivity of different neurons onto pyramidal cells in a 3D reconstruction of the rat hippocampus. Front Neuroinform 2011, 5:5.
44. Rosso A., Mossey J., Lippa C.F. Caffeine: neuroprotective functions in cognition and Alzheimer's disease. Am J Alzheimers Dis Other Demen 2008, 23:417-422.
45. Santos C., Costa J., Santos J., Vaz-Carneiro A., Lunet N. Caffeine intake and dementia: systematic review and meta-analysis. J Alzheimers Dis 2010, 20(Suppl 1):S187-S204.
46. Santos C., Lunet N., Azevedo A., de Mendonça A., Ritchie K., Barros H. Caffeine intake is associated with a lower risk of cognitive decline: a cohort study from Portugal. J Alzheimers Dis 2010, 20(Suppl 1):S175-S185.
47. Simons SB, Caruana DA, Zhao M, Dudek SM (in press) Caffeine-induced synaptic potentiation in hippocampal CA2 neurons. Nat Neurosci, doi:10.1038/nn.2962.
48. 3H]2-deoxyglucose uptake in mice. Psychobiology 1992, 20:270-279.
49. Takahashi R.N., Pamplona F.A., Prediger R.D. Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies. Front Biosci 2008, 13:2614-2632.
50. Van Gelder B.M., Buijsse B., Tijhuis M., Kalmijn S., Giampaoli S., Nissinen A., Kromhout D. Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE study. Eur J Clin Nutr 2007, 61:226-232.
51. Walf A.A., Frye C.A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2007, 2:322-328.
52. Willig F., Palacios A., Monmaur P., M'Harzi M., Laurent J., Delacour J. Short-term memory, exploration and locomotor activity in aged rats. Neurobiol Aging 1987, 8:393-402.
53. Xu K., Xu Y., Brown-Jermyn D., Chen J.F., Ascherio A., Dluzen D.E., Schwarzschild M.A. Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Neurosci 2006, 26:535-541.
54. 2A receptor knockout mice with microarray profiling. Physiol Genomics 2009, 37:199-210.
55. Zhao M., Choi Y.S., Obrietan K., Dudek S.M. Synaptic plasticity (and the lack thereof) in hippocampal CA2 neurons. J Neurosci 2007, 27:12025-12032.